-
1
-
-
85082528685
-
Preserving clinical trial integrity during the coronavirus pandemic
-
[E-pub ahead of print]
-
McDermott, M.M., Newman, A.B., Preserving clinical trial integrity during the coronavirus pandemic. JAMA, 2020 Mar 25 [E-pub ahead of print].
-
(2020)
JAMA
-
-
McDermott, M.M.1
Newman, A.B.2
-
2
-
-
85086888000
-
Pandemic pandemonium: pausing clinical research during the COVID-19 outbreak
-
[E-pub ahead of print]
-
Byrd, J.B., Bello, N., Meyer, M.N., Pandemic pandemonium: pausing clinical research during the COVID-19 outbreak. Circulation, 2020 Apr 22 [E-pub ahead of print].
-
(2020)
Circulation
-
-
Byrd, J.B.1
Bello, N.2
Meyer, M.N.3
-
3
-
-
85087525798
-
UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19). Notice document. March 26, 2020
-
Available at: (Accessed 26 March 2020)
-
National Institutes of Health. UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19). Notice document. March 26, 2020. Available at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-091.html. (Accessed 26 March 2020)
-
-
-
-
4
-
-
85083113377
-
FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency. Guidance document. March 2020
-
Available at: (Accessed 20 March 2020)
-
U.S. Food and Drug Administration. FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency. Guidance document. March 2020. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic. (Accessed 20 March 2020)
-
-
-
-
5
-
-
85083726739
-
Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic
-
Driggin, E., Madhavan, M.V., Bikdeli, B., et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 75 (2020), 2352–2371.
-
(2020)
J Am Coll Cardiol
, vol.75
, pp. 2352-2371
-
-
Driggin, E.1
Madhavan, M.V.2
Bikdeli, B.3
-
6
-
-
85081308923
-
How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital
-
Zeng, J., Huang, J., Pan, L., How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital. Intensive Care Med 46 (2020), 1111–1113.
-
(2020)
Intensive Care Med
, vol.46
, pp. 1111-1113
-
-
Zeng, J.1
Huang, J.2
Pan, L.3
-
7
-
-
84978064544
-
Adaptive designs for clinical trials
-
Bhatt, D.L., Mehta, C., Adaptive designs for clinical trials. N Engl J Med 375 (2016), 65–74.
-
(2016)
N Engl J Med
, vol.375
, pp. 65-74
-
-
Bhatt, D.L.1
Mehta, C.2
-
8
-
-
85087517476
-
Lexicon Pharmaceuticals Provides an Update on the Sotagliflozin Type 2 Diabetes Program
-
Available at: (Accessed 20 March 2020)
-
Lexicon Pharmaceuticals. Lexicon Pharmaceuticals Provides an Update on the Sotagliflozin Type 2 Diabetes Program. Globe newswire, March 19, 2020 Available at: https://www.benzinga.com/pressreleases/20/03/g15611401/lexicon-pharmaceuticals-provides-an-update-on-the-sotagliflozin-type-2-diabetes-program. (Accessed 20 March 2020)
-
(2020)
Globe newswire
-
-
-
9
-
-
84903885738
-
Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies
-
Lynfield, R., Davey, R., Dwyer, D.E., et al., for the INSIGHT Influenza Study Group. Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One, 9, 2014, e101785.
-
(2014)
PLoS One
, vol.9
-
-
Lynfield, R.1
Davey, R.2
Dwyer, D.E.3
-
10
-
-
85082548731
-
Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID19 Mortality and Healthcare Demand
-
Imperial College of London London, UK
-
Ferguson, N.M., Laydon, D., Nedjati-Gilani, G., et al. Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID19 Mortality and Healthcare Demand. 2020, Imperial College of London, London, UK.
-
(2020)
-
-
Ferguson, N.M.1
Laydon, D.2
Nedjati-Gilani, G.3
|